Azathioprine-induced lymphoma manifesting as fulminant hepatic failure

Mayo Clin Proc. 1997 Jul;72(7):643-5. doi: 10.1016/S0025-6196(11)63570-2.

Abstract

Azathioprine and rheumatoid arthritis are known to be associated with an increased risk of the development of non-Hodgkin's lymphoma; however, the manifestation of fulminant hepatic failure is extremely uncommon in patients with non-Hodgkin's lymphoma. In this article, we describe a patient with rheumatoid arthritis who was taking azathioprine, in whom fulminant hepatic failure occurred because of massive lymphomatous infiltration of the liver.

Publication types

  • Case Reports

MeSH terms

  • Antirheumatic Agents / adverse effects*
  • Antirheumatic Agents / therapeutic use
  • Arthritis, Rheumatoid / drug therapy
  • Azathioprine / adverse effects*
  • Azathioprine / therapeutic use
  • Chemical and Drug Induced Liver Injury / complications
  • Chemical and Drug Induced Liver Injury / etiology*
  • Fatal Outcome
  • Female
  • Humans
  • Liver Neoplasms / chemically induced*
  • Liver Neoplasms / diagnostic imaging
  • Liver Neoplasms / pathology
  • Lymphoma, Large-Cell, Anaplastic / chemically induced*
  • Lymphoma, Large-Cell, Anaplastic / diagnostic imaging
  • Lymphoma, Large-Cell, Anaplastic / pathology
  • Middle Aged
  • Ultrasonography

Substances

  • Antirheumatic Agents
  • Azathioprine